SEC Form 13F
| Report period | 2026-06-30 |
|---|---|
| Publicly available | 2026-08-15 |
| Reported value | $179,307,999 |
| Positions | 37 |
| Issuer | Ticker | Class | Reported value | Reported amount |
|---|---|---|---|---|
| MeiraGTX Holdings | MGTX | COM | $16,887,500 | 1,250,000 |
| Sprott physical gold Trust | PHYS | Physical Gold Tr | $11,677,449 | 387,055 |
| Aldeyra Therapeutics Inc | ALDX | COM | $11,662,849 | 5,475,516 |
| Ocular Therapeutix Inc. | OCUL | COM | $11,296,928 | 1,150,400 |
| Royal Gold Inc. | RGLD | COM | $10,529,427 | 52,750 |
| Entera Bio Ltd | Unresolved | SHS | $10,410,925 | 5,881,879 |
| Nuvation Bio Inc | NUVB | COM CL A | $9,079,996 | 1,598,591 |
| Agnico Eagle Mines Ltd | AEM | COM | $8,183,107 | 52,750 |
| SEABRIDGE GOLD INC | SEA | COM | $8,159,657 | 317,003 |
| Kinross Gold Corp | KGC | COM | $7,558,400 | 320,000 |
Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.